Michael Hecker

Felix Hausdorff Str. 8
Greifswald, MV 17489, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 175 publications

Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal Study.

Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal Study.

Journal: Neurology and therapy

Published: May 07, 2026

Bayes at the Bedside: Biomarkers in Situations of Clinical Uncertainty.

Bayes at the Bedside: Biomarkers in Situations of Clinical Uncertainty.

Journal: Diagnostics (Basel, Switzerland)

Published: April 30, 2026

Real-world data on the prevalence and therapy of symptomatic bladder dysfunction in people with multiple sclerosis.

Real-world data on the prevalence and therapy of symptomatic bladder dysfunction in people with multiple sclerosis.

Journal: Therapeutic advances in neurological disorders

Published: January 07, 2026

Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.

Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.

Journal: The Lancet. Neurology

Published: October 15, 2025

Personality Traits and Their Association With Medication Non-Adherence in Patients With Multiple Sclerosis.

Personality Traits and Their Association With Medication Non-Adherence in Patients With Multiple Sclerosis.

Journal: CNS neuroscience & therapeutics

Published: May 26, 2025

Discrepancy Between Vaccination Willingness and Actual SARS-CoV-2 Vaccination Status in People with Multiple Sclerosis: A Longitudinal Study.

Discrepancy Between Vaccination Willingness and Actual SARS-CoV-2 Vaccination Status in People with Multiple Sclerosis: A Longitudinal Study.

Journal: Journal of clinical medicine

Published: March 25, 2025

Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 Pandemic.

Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 Pandemic.

Journal: Journal of clinical medicine

Published: March 11, 2025

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.

Journal: Frontiers in immunology

Published: November 20, 2024

Cost patterns of long-term prescribed medications in patients with multiple sclerosis in Germany.

Cost patterns of long-term prescribed medications in patients with multiple sclerosis in Germany.

Journal: Scientific reports

Published: November 01, 2024

Activation of the general stress response sigma factor SigB prevents competence development in Bacillus subtilis.

Activation of the general stress response sigma factor SigB prevents competence development in Bacillus subtilis.

Journal: mBio

Published: October 29, 2024

Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacy.

Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacy.

Journal: Therapeutic advances in neurological disorders

Published: May 30, 2024

Challenges in monitoring the quality of care in multiple sclerosis.

Challenges in monitoring the quality of care in multiple sclerosis.

Journal: The Lancet regional health. Europe

Published: April 19, 2024

Showing 1-12 of 175

Last Updated: 09/26/2026